Live Nasdaq Composite: Stocks Sink on Worrisome Q2 Tech Earnings, Oil Retakes $100

Investing

Merck : MRK

All Merck Articles

1089 Articles

Jon C. Ogg | Jun 25, 2012 at 8:21 AM EDT

Top Analyst Upgrades & Downgrades (ABB, ALK, ACI, ARNA, AN, ADP, BOKF, BA, CCL, MRK, NFLX, PAYX, PM, RHT, RIMM, SNDK, WWWW)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Monday.…

Jon C. Ogg | Jun 22, 2012 at 8:26 AM EDT

Top Analyst Upgrades & Downgrades (CELG, CIM, GLW, DFS, EA, FB, JEF, KMB, LAZ, MSI, ONXX, PBY, RL, RGR, SXCI, TROW, MRK, ILMN, PG)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Friday.…

Jon C. Ogg | Jun 5, 2012 at 8:16 AM EDT

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) is back in the rumor mill as far as a buyout, but this time the…

Jon C. Ogg | May 31, 2012 at 11:13 AM EDT

Investors Flocking To Defensive Shares With High Dividends (PEP, KO, BUD, TAP, AWK, AEP, XLU, MCD, KFT, CAG, CPB, HRL, MO, VGR, RAI, PG, KMB, CL, MRK, PFE, JNJ, T, VZ)

The 10-year Treasury hit yet another record low under 1.6% today and stocks are in the tank again due to…

Jon C. Ogg | May 14, 2012 at 1:14 PM EDT

Investors Seeking Defensive Stocks Where 3% to Over 5% Dividends Rule!

A stock market that sells off eight of nine days is not a good market. Even the Facebook IPO is…

Jon C. Ogg | May 8, 2012 at 12:07 PM EDT

The Market Where Defensive Shares Are Working Again (PEP, KO, BUD, TAP, AWK, MCD, KFT, CAG, CPB, HRL, MO, VGR, RAI, PG, KMB, CL, MRK, PFE, JNJ, T, VZ)

Blame whatever you want. A weaker U.S. economy, a weakening and flailing Europe, a move to socialism in France and…

Paul Ausick | Apr 27, 2012 at 4:05 PM EDT

24/7 Wall St. Closing Bell (PM, SNDK, BIDU, AMZN, ALU, ELY, CLWR, DECK, WY, TRP, GT, PG, NWL, MRK, HELE, F, COV, CVX, MDRX, EXPE, WDC)

Markets opened higher this morning following a lower-than-expected GDP growth estimate of 2.2%. That was weaker, but not awful (our…

Jon C. Ogg | Apr 27, 2012 at 9:15 AM EDT

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is supposed to be acquired by a larger drug company. It is one of the…

Jon C. Ogg | Apr 26, 2012 at 11:13 AM EDT

J&J Joins Dividend Hike One-Up Game (JNJ, PFE, MRK)

How many DJIA components can raise their dividend in one week? Johnson & Johnson (NYSE: JNJ) answered that question as…

Jon C. Ogg | Apr 23, 2012 at 2:54 PM EDT

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Ardea Biosciences, Inc. (NASDAQ: RDEA) is soaring today on news that AstraZeneca PLC (NYSE: AZN) is paying about $1.26 billion to…

Paul Ausick | Apr 23, 2012 at 7:59 AM EDT

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Diabetes drug maker Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) has hired bankers and lawyers to help the company find a buyer.…

Douglas A. McIntyre | Apr 16, 2012 at 6:34 AM EDT

Media Digest (4/16/2012) Reuters, WSJ, NYT, FT

Concerns about Spain and Italy renew capital markets’ rejection of area debt. (Reuters) Best Buy (NYSE: BBY) will have to…

Paul Ausick | Mar 19, 2012 at 11:11 AM EDT

Biopharma Firm Crushed by Merck Deal Cancellation (CRME, MRK)

Canadian-based drug company Cardiome Pharma Corp. (NASDAQ: CRME) announced this morning that Merck & Co. Inc. (NYSE: MRK) has cancelled…

Paul Ausick | Mar 6, 2012 at 8:55 AM EST

Merck Lowers First Quarter Outlook (MRK)

Drug maker Merck & Co. Inc. (NYSE: MRK) this morning lowered its first quarter non-GAAP EPS estimate to $0.95-$0.98, well…

Paul Ausick | Mar 5, 2012 at 9:40 AM EST

Merck’s Ragweed Allergy Drug Results Good (MRK)

Drug maker Merck & Co. Inc. (NYSE: MRK) has released results of a phase III study of its investigational allergy…

1 … 57 58 59 60 61 … 73

Merck : MRK

All Merck Articles

Top Analyst Upgrades & Downgrades (ABB, ALK, ACI, ARNA, AN, ADP, BOKF, BA, CCL, MRK, NFLX, PAYX, PM, RHT, RIMM, SNDK, WWWW)

Top Analyst Upgrades & Downgrades (CELG, CIM, GLW, DFS, EA, FB, JEF, KMB, LAZ, MSI, ONXX, PBY, RL, RGR, SXCI, TROW, MRK, ILMN, PG)

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Investors Flocking To Defensive Shares With High Dividends (PEP, KO, BUD, TAP, AWK, AEP, XLU, MCD, KFT, CAG, CPB, HRL, MO, VGR, RAI, PG, KMB, CL, MRK, PFE, JNJ, T, VZ)

Investors Seeking Defensive Stocks Where 3% to Over 5% Dividends Rule!

The Market Where Defensive Shares Are Working Again (PEP, KO, BUD, TAP, AWK, MCD, KFT, CAG, CPB, HRL, MO, VGR, RAI, PG, KMB, CL, MRK, PFE, JNJ, T, VZ)

24/7 Wall St. Closing Bell (PM, SNDK, BIDU, AMZN, ALU, ELY, CLWR, DECK, WY, TRP, GT, PG, NWL, MRK, HELE, F, COV, CVX, MDRX, EXPE, WDC)

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

J&J Joins Dividend Hike One-Up Game (JNJ, PFE, MRK)

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Media Digest (4/16/2012) Reuters, WSJ, NYT, FT

Biopharma Firm Crushed by Merck Deal Cancellation (CRME, MRK)

Merck Lowers First Quarter Outlook (MRK)

Merck’s Ragweed Allergy Drug Results Good (MRK)

Live Nasdaq Composite: Stocks Sink on Worrisome Q2 Tech Earnings, Oil Retakes $100

Live: Can Intel Continue Its Meteoric 327% Run With Q2 Earnings Tonight?

Live: Will Decker Brands Beat Q1 Earnings Tonight After the Market Closes?

If The Stock Market Bottomed Last Week: These 3 Stocks Could Triple From Today’s Prices

At $100 Per Barrel, Which Oil Stock Has Dominated in 2026: ExxonMobil, Chevron, or BP?

I’m Buying ‘Fully Priced’ AMD Because The Math Says I Should

Why Pulling From Your IRA Before Your Taxable Account Still Costs Retirees Five Figures, Even With No Penalty

Roth Conversion Strategy Cuts $1.5 Million 401(k) Tax Bills in Half for Early Retirees

If The Stock Market Bottomed Last Week: These 3 Stocks Could Triple From Today’s Prices

Live: Will Decker Brands Beat Q1 Earnings Tonight After the Market Closes?

Merck : MRK

All Merck Articles

Top Analyst Upgrades & Downgrades (ABB, ALK, ACI, ARNA, AN, ADP, BOKF, BA, CCL, MRK, NFLX, PAYX, PM, RHT, RIMM, SNDK, WWWW)

Top Analyst Upgrades & Downgrades (CELG, CIM, GLW, DFS, EA, FB, JEF, KMB, LAZ, MSI, ONXX, PBY, RL, RGR, SXCI, TROW, MRK, ILMN, PG)

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Investors Flocking To Defensive Shares With High Dividends (PEP, KO, BUD, TAP, AWK, AEP, XLU, MCD, KFT, CAG, CPB, HRL, MO, VGR, RAI, PG, KMB, CL, MRK, PFE, JNJ, T, VZ)

Investors Seeking Defensive Stocks Where 3% to Over 5% Dividends Rule!

The Market Where Defensive Shares Are Working Again (PEP, KO, BUD, TAP, AWK, MCD, KFT, CAG, CPB, HRL, MO, VGR, RAI, PG, KMB, CL, MRK, PFE, JNJ, T, VZ)

24/7 Wall St. Closing Bell (PM, SNDK, BIDU, AMZN, ALU, ELY, CLWR, DECK, WY, TRP, GT, PG, NWL, MRK, HELE, F, COV, CVX, MDRX, EXPE, WDC)

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

J&J Joins Dividend Hike One-Up Game (JNJ, PFE, MRK)

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Media Digest (4/16/2012) Reuters, WSJ, NYT, FT

Biopharma Firm Crushed by Merck Deal Cancellation (CRME, MRK)

Merck Lowers First Quarter Outlook (MRK)

Merck’s Ragweed Allergy Drug Results Good (MRK)

Live Nasdaq Composite: Stocks Sink on Worrisome Q2 Tech Earnings, Oil Retakes $100

Live: Can Intel Continue Its Meteoric 327% Run With Q2 Earnings Tonight?

Live: Will Decker Brands Beat Q1 Earnings Tonight After the Market Closes?

If The Stock Market Bottomed Last Week: These 3 Stocks Could Triple From Today’s Prices

At $100 Per Barrel, Which Oil Stock Has Dominated in 2026: ExxonMobil, Chevron, or BP?

I’m Buying ‘Fully Priced’ AMD Because The Math Says I Should

Featured Reads

Why Pulling From Your IRA Before Your Taxable Account Still Costs Retirees Five Figures, Even With No Penalty

Roth Conversion Strategy Cuts $1.5 Million 401(k) Tax Bills in Half for Early Retirees